Figure 3. Overall (A) and recurrence-free (B) actuarial survival (%) after major liver resection for hepatocellular carcinoma in injured liver in 19 patients without (dashed lines) and in 9 patients with preoperative portal vein embolization (solid lines). (P = .99 and .2, respectively, log-rank)